BMS-986249

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986249, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors [Phase 1, Phase 2]